Sign in
Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome
Journal article   Open access   Peer reviewed

Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome

A. Moore, A.K. Burrows, R. Malik, R.M. Ghubash, R.D. Last and B. Remaj
Veterinary Dermatology, Vol.33(5), pp.435-439
2022
pdf
toxoplasmosis.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Toxoplasma gondii is a ubiquitous protozoan, for which felids are the definitive host. Immunocompromised individuals are susceptible to recrudescent toxoplasmosis. This case describes a 6-year-old, feline immunodeficiency virus-positive domestic short hair cat with feline atopic skin syndrome that developed fatal toxoplasmosis after treatment with oclacitinib for five months.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

154 File views/ downloads
149 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.65 Allergy
1.65.1091 Atopic Dermatitis
Web Of Science research areas
Dermatology
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image